Related Experiment Video
Updated: Jan 21, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
CNS-targeting pharmacological interventions for the metabolic syndrome
Kerstin Stemmer1,2, Timo D Müller1,2, Richard D DiMarchi3
1Institute for Diabetes and Obesity, Helmholtz Zentrum München, Neuherberg, Germany.
Abstract:
The metabolic syndrome (MetS) encompasses medical conditions such as obesity, hyperglycemia, high blood pressure, and dyslipidemia that are major drivers for the ever-increasing prevalence of type 2 diabetes, cardiovascular diseases, and certain types of cancer. At the core of clinical strategies against the MetS is weight loss, induced by bariatric surgery, lifestyle changes based on calorie reduction and exercise, or pharmacology. This Review summarizes the past, current, and future efforts of targeting the MetS by pharmacological agents. Major emphasis is given to drugs that target the CNS as a key denominator for obesity and its comorbid sequelae.
More Related Videos
Related Concept Videos
Nursing Interventions I: Taxonomy of Nursing Interventions
A nursing intervention is a treatment or action based on scientific concepts and knowledge from the nursing, behavioral, and physical sciences. Identifying and prioritizing nursing interventions based on the desired outcome...
What is Metabolism?
Nursing Interventions II: Selecting and Classifying the Nursing Interventions
CNS Depressants: Alcohol and Nicotine
CNS Depressants: Barbiturates and Benzodiazepines
CNS Stimulants: Psychedelic Agents

